TriSalus Life Sciences, Inc. (TLSI): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$26.32M
Year ended 2025-12-31
-$29.95M
Trailing 12 months to 2026-06-30
2022-12-31: -$36.04M2023-12-31: -$53.79M2024-12-31: -$35.42M2025-12-31: -$26.32M-$26.32M
2022-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$26.32Mn/m2026-03-05, From 2025-01-01
2024-12-31-$35.42Mn/m2026-03-05, From 2024-01-01
2023-12-31-$53.79Mn/c2025-05-30, From 2023-01-01
2022-12-31-$36.04Mn/a2024-04-11, From 2022-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
TriSalus Life Sciences, Inc. (TLSI)2025-12-31-$26.32Mn/m
SANUWAVE Health, Inc. (SNWV)2025-12-31$5.92M+27.7%
SS Innovations International, Inc. (SSII)2025-12-31-$7.12Mn/m
KORU Medical Systems, Inc. (KRMD)2025-12-31-$2.16Mn/m
Carlsmed, Inc. (CARL)2025-12-31-$30.29Mn/m
Interpace Biosciences, Inc. (IDXG)2025-12-31$4.51M-46.4%
Apyx Medical Corp (APYX)2025-12-31-$5.79Mn/m
Retractable Technologies Inc (RVP)2025-12-31-$13.41Mn/m
Cytosorbents Corp (CTSO)2025-12-31-$13.52Mn/m

Compare TLSI, SNWV, SSII, KRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗